At 82, your memory could work like someone's who's 50. It happens more often than you'd think, and researchers just found a genetic clue that might explain it.
Scientists studying "super agers" — people over 80 whose thinking and memory rival folks two decades younger — discovered something striking: they're far less likely to carry a gene variant that dramatically raises Alzheimer's risk. The study, the largest of its kind, tracked over 18,000 people across eight aging cohorts and found that super agers were 68% less likely to have the APOE-ε4 gene variant, the strongest known risk factor for late-onset Alzheimer's disease.
The flip side matters too. Super agers were 28% more likely to carry APOE-ε2, a variant linked to reduced Alzheimer's risk. Compared to people with Alzheimer's dementia, super agers were twice as likely to have this protective gene.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxWhat makes this research matter isn't just the numbers. For decades, Alzheimer's research has focused on what goes wrong — plaques, tangles, inflammation. This study shifts the lens. Instead of asking "Why do some people get sick?", researchers are now asking "What lets some people stay sharp?" That's a different kind of question, and it might lead somewhere new.
The researchers defined super agers as those over 80 whose memory scores matched the average for cognitively normal 50- to 64-year-olds. The study included over 1,600 of them — both non-Hispanic white and Black participants — making this the most diverse analysis of super aging genetics to date.
Lead researcher Leslie Gaynor notes that understanding the genetic factors protecting these sharp minds could unlock insights into preventing and treating dementia. It's not a cure, and genetics isn't destiny — lifestyle, education, and social connection all matter. But knowing which genes confer resilience gives researchers a concrete target. Instead of fighting Alzheimer's after it starts, they might eventually help more people build the kind of cognitive reserve that keeps some minds young.
The next phase is obvious: what do these protective genes actually do? How do they shield the brain? Those answers could reshape how we think about aging and memory.
